Technical Analysis for CRMD - CorMedix Inc

Grade Last Price % Change Price Change
grade A 1.71 -10.00% -0.19
CRMD closed down 10.0 percent on Friday, January 18, 2019, on 1.78 times normal volume.
76 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical CRMD trend table...

Date Alert Name Type % Chg
Jan 18 Calm After Storm Range Contraction 0.00%
Jan 18 Upper Bollinger Band Walk Strength 0.00%
Jan 18 Inside Day Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Slingshot Bullish Bullish Swing Setup -10.00%
Jan 17 Volume Surge Other -10.00%
Jan 17 Wide Range Bar Range Expansion -10.00%
Jan 17 Upper Bollinger Band Walk Strength -10.00%
Jan 17 Outside Day Range Expansion -10.00%
Jan 17 Wide Bands Range Expansion -10.00%

Older signals for CRMD ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
CorMedix Inc., a development stage pharmaceutical and medical device company, focuses on in-license, development, and commercialization of therapeutic products for the treatment of cardiac and renal dysfunction primarily in the dialysis and non-dialysis areas. It develops CRMD003 (Neutrolin), an antimicrobial/antifungal and anticoagulant combination in liquid formulation; and CRMD004, gel formulation of Neutrolin for the prevention of catheter-related blood stream infections and maintenance of catheter patency in hemodialysis patients. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix Inc. in January 2007. CorMedix Inc. was founded in 2006 and is based in Bridgewater, New Jersey.
Is CRMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jan 18 TSLA and LXRX among premarket losers
Jan 17 These 4 Healthcare Stocks Are Raising Expectations
Jan 17 MBOT, KNX among premarket gainers
Jan 17 CorMedix up 16% premarket on positive Neutrolin data
Jan 17 Cormedix Inc. Announces Highly Statistically Significant Topline Results For Neutrolin(R) From The Interim Analysis Of The Phase 3 Lock-It-100 Study
Jan 16 CorMedix Inc. Announces Resignation of Member of Its Board of Directors
Jan 16 Today's Research Reports on Trending Tickers: Incyte and CorMedix
Jan 15 Mid-Day Market Update: Crude Oil Up 3%; Bio-Path Holdings Shares Plummet
Jan 9 This Stock Generated 25X Returns In Just Five Years: Could BTCY Be At The Same Crossroads?
Jan 4 Cormedix closes $7.5M senior secured convertible debt financing
See more CRMD news...
Indicators
Indicator Value
52 Week High 2.4
52 Week Low 0.17
Average Volume 2,609,286
200-Day Moving Average 0.757
50-Day Moving Average 1.408
20-Day Moving Average 1.544
10-Day Moving Average 1.755
Average True Range 0.2029
ADX 29.63
+DI 27.8302
-DI 16.3088
Chandelier Exit (Long, 3 ATRs ) 1.6513
Chandelier Exit (Short, 3 ATRs ) 1.7187
Upper Bollinger Band 2.0318
Lower Bollinger Band 1.0562
Percent B (%b) 0.67
BandWidth 63.186528
MACD Line 0.128
MACD Signal Line 0.1032
MACD Histogram 0.0248
Fundamentals Value
Market Cap 101.27 Million
Num Shares 59.2 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -2.61
Price-to-Sales 98.06
Price-to-Book 2.19
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.94
Resistance 3 (R3) 1.94 1.87 1.90
Resistance 2 (R2) 1.87 1.81 1.87 1.88
Resistance 1 (R1) 1.79 1.78 1.76 1.79 1.87
Pivot Point 1.72 1.72 1.70 1.72 1.72
Support 1 (S1) 1.64 1.66 1.61 1.64 1.55
Support 2 (S2) 1.57 1.63 1.57 1.54
Support 3 (S3) 1.49 1.57 1.52
Support 4 (S4) 1.49